Chammas R - Search Results

1

Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma.

Rocha FG, Calvo FB, Chaves KC, Peron JP, Marques RF, de Borba TR, Braga MS, Pereira CB, Vicente EJ, Chammas R, Schor N, Bellini MH. Rocha FG, et al. Among authors: chammas r. J Gene Med. 2011 Mar;13(3):148-57. doi: 10.1002/jgm.1547. J Gene Med. 2011. PMID: 21344541

2

Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor.

Novak EM, Metzger M, Chammas R, da Costa M, Dantas K, Manabe C, Pires J, de Oliveira AC, Bydlowski SP. Novak EM, et al. Among authors: chammas r. Gene Ther. 2003 Nov;10(23):1992-7. doi: 10.1038/sj.gt.3302111. Gene Ther. 2003. PMID: 14528323

3

Anti-tumor effect of endostatin mediated by retroviral gene transfer in mice bearing renal cell carcinoma.

Coutinho EL, Andrade LN, Chammas R, Morganti L, Schor N, Bellini MH. Coutinho EL, et al. Among authors: chammas r. FASEB J. 2007 Oct;21(12):3153-61. doi: 10.1096/fj.07-8412com. Epub 2007 May 18. FASEB J. 2007. PMID: 17513560

4

Anti-tumor therapy with macroencapsulated endostatin producer cells.

Rodrigues DB, Chammas R, Malavasi NV, da Costa PL, Chura-Chambi RM, Balduino KN, Morganti L. Rodrigues DB, et al. Among authors: chammas r. BMC Biotechnol. 2010 Mar 2;10:19. doi: 10.1186/1472-6750-10-19. BMC Biotechnol. 2010. PMID: 20196841 Free PMC article.

5

Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice.

Rocha FG, Chaves KC, Chammas R, Peron JP, Rizzo LV, Schor N, Bellini MH. Rocha FG, et al. Among authors: chammas r. Cancer Immunol Immunother. 2010 Sep;59(9):1357-65. doi: 10.1007/s00262-010-0865-6. Epub 2010 May 20. Cancer Immunol Immunother. 2010. PMID: 20490489 Free PMC article.

6

Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinoma.

de Souza Braga M, Chaves KB, Chammas R, Schor N, Bellini MH. de Souza Braga M, et al. Among authors: chammas r. Biomed Pharmacother. 2012 Jun;66(4):237-41. doi: 10.1016/j.biopha.2011.11.002. Epub 2011 Dec 21. Biomed Pharmacother. 2012. PMID: 22560459

7

Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model.

Chaves KC, Peron JP, Chammas R, Turaça LT, Pesquero JB, Braga MS, Foguer K, Schor N, Bellini MH. Chaves KC, et al. Among authors: chammas r. Cancer Gene Ther. 2012 Aug;19(8):558-65. doi: 10.1038/cgt.2012.32. Epub 2012 Jun 15. Cancer Gene Ther. 2012. PMID: 22699868

8

Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy.

Chaves KC, Turaça LT, Pesquero JB, Mennecier G, Dagli ML, Chammas R, Schor N, Bellini MH. Chaves KC, et al. Among authors: chammas r. Biomed Pharmacother. 2012 Sep;66(6):464-8. doi: 10.1016/j.biopha.2012.04.003. Epub 2012 May 11. Biomed Pharmacother. 2012. PMID: 22920414

9

Vascular endothelial growth factor as a biomarker for endostatin gene therapy.

Braga MS, Turaça TL, Foguer K, Chaves KC, Pesquero JB, Chammas R, Schor N, Bellini MH. Braga MS, et al. Among authors: chammas r. Biomed Pharmacother. 2013 Jul;67(6):511-5. doi: 10.1016/j.biopha.2013.04.008. Epub 2013 May 6. Biomed Pharmacother. 2013. PMID: 23726969

10

Expression of the selectable marker gene bsrm in BALB/MK cells induces apoptosis by overproduction of hydrogen peroxide.

Takeshita D, Bento FM, Chammas R, Belizário JE, Carmona AK, Konno K, Lopes de Melo R, Molina G, Lisboa BC, Han SW. Takeshita D, et al. Among authors: chammas r. Biochem Cell Biol. 2007 Oct;85(5):573-81. doi: 10.1139/o07-058. Biochem Cell Biol. 2007. PMID: 17901899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

253 results

Search Page